FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4379280904> ?p ?o ?g. }

• W4379280904 endingPage "e20570" @default.
• W4379280904 startingPage "e20570" @default.
• W4379280904 abstract "e20570 Background: For locally advanced unresectable NSCLC, studies of PD-1 inhibitor plus chemo as induction therapy and its roles on subsequent surgical resection are still limited. In this study, a consecutive series of unresectable stage III NSCLC patients were collected to investigate the surgical outcome and postoperative symptom changes in locally advanced patients who received adjuvant chemotherapy combined with immunotherapy. Methods: 92 locally advanced NSCLC patients received 2-4 cycles of chemotherapy combined with immunotherapy. Surgical rates, major pathologic remissions(MPR), pathologic complete remissions(PCR), postoperative complications, and immune-related adverse reactions(irAEs) were assesd. The follow-up of symptoms was performed during treatment and within 3 months postoperatively, and symptom changes were described based on patient-reported outcomes. Results: 26.09% of patients developed irAEs, the most common was skin toxicity, followed by thyroid dysfunction. 71.74% of patients underwent surgical resection. 63.64% (42/66) achieved MPR and PCR, of which 37.87% (25/66) were PCR. Most of these patients have clinical symptoms at the time of presentation, mainly cough (90%), and after treatment, cough is significantly reduced compared with before treatment. After treatment, the cough was significantly reduced compared with before treatment , nausea and vomiting , loss of appetite , dry mouth , and diarrhea were increased or aggravated. The most common symptoms on the first day after operation included pain (90%), shortness of breath (62.5%), fatigue (45%), cough (42.5%), and dry mouth (37.5%). On the third day after surgery, the incidence and severity of each symptom changed significantly, pain and dry mouth decreased significantly compared with before, cough, shortness of breath, and fatigue worsened and the incidence increased. Pain remains the most severe symptom in the early postoperative period, with the most severe on the first day after operation and then reduced, returning to preoperative levels 1.5 months after surgery. Cough was the main symptom at the time of presentation, which was significantly reduced after preoperative treatment, and the incidence and severity of postoperative cough increased significantly compared with preoperative treatment and returned to the preoperative level within 1 week after surgery. Dyspnea lasts long after surgery. Two weeks after surgery, shortness of breath (dyspnea) becomes the most obvious symptom. Conclusions: Preoperative chemotherapy combined with immunotherapy provides more opportunities for radical resection in locally advanced NSCLC patients. The most common postoperative symptoms are pain, dyspnea, cough, and fatigue; dyspnea is the symptom that affects patients the most and lasts the longest after surgery." @default.
• W4379280904 created "2023-06-05" @default.
• W4379280904 creator A5000241698 @default.
• W4379280904 creator A5001260755 @default.
• W4379280904 creator A5021626853 @default.
• W4379280904 creator A5062388901 @default.
• W4379280904 date "2023-06-01" @default.
• W4379280904 modified "2023-09-25" @default.
• W4379280904 title "Surgical outcomes and patient-reported outcomes of unresectable stage III non-small cell lung cancer patients who underwent PD-1 inhibitor plus chemo as induction therapy." @default.
• W4379280904 doi "https://doi.org/10.1200/jco.2023.41.16_suppl.e20570" @default.
• W4379280904 hasPublicationYear "2023" @default.
• W4379280904 type Work @default.
• W4379280904 citedByCount "0" @default.
• W4379280904 crossrefType "journal-article" @default.
• W4379280904 hasAuthorship W4379280904A5000241698 @default.
• W4379280904 hasAuthorship W4379280904A5001260755 @default.
• W4379280904 hasAuthorship W4379280904A5021626853 @default.
• W4379280904 hasAuthorship W4379280904A5062388901 @default.
• W4379280904 hasConcept C121608353 @default.
• W4379280904 hasConcept C126322002 @default.
• W4379280904 hasConcept C141071460 @default.
• W4379280904 hasConcept C146357865 @default.
• W4379280904 hasConcept C151730666 @default.
• W4379280904 hasConcept C197934379 @default.
• W4379280904 hasConcept C2776256026 @default.
• W4379280904 hasConcept C2776694085 @default.
• W4379280904 hasConcept C2778375690 @default.
• W4379280904 hasConcept C2780580376 @default.
• W4379280904 hasConcept C2780852908 @default.
• W4379280904 hasConcept C71924100 @default.
• W4379280904 hasConcept C86803240 @default.
• W4379280904 hasConceptScore W4379280904C121608353 @default.
• W4379280904 hasConceptScore W4379280904C126322002 @default.
• W4379280904 hasConceptScore W4379280904C141071460 @default.
• W4379280904 hasConceptScore W4379280904C146357865 @default.
• W4379280904 hasConceptScore W4379280904C151730666 @default.
• W4379280904 hasConceptScore W4379280904C197934379 @default.
• W4379280904 hasConceptScore W4379280904C2776256026 @default.
• W4379280904 hasConceptScore W4379280904C2776694085 @default.
• W4379280904 hasConceptScore W4379280904C2778375690 @default.
• W4379280904 hasConceptScore W4379280904C2780580376 @default.
• W4379280904 hasConceptScore W4379280904C2780852908 @default.
• W4379280904 hasConceptScore W4379280904C71924100 @default.
• W4379280904 hasConceptScore W4379280904C86803240 @default.
• W4379280904 hasIssue "16_suppl" @default.
• W4379280904 hasLocation W43792809041 @default.
• W4379280904 hasOpenAccess W4379280904 @default.
• W4379280904 hasPrimaryLocation W43792809041 @default.
• W4379280904 hasRelatedWork W2081557631 @default.
• W4379280904 hasRelatedWork W2111792237 @default.
• W4379280904 hasRelatedWork W2156337883 @default.
• W4379280904 hasRelatedWork W2262648772 @default.
• W4379280904 hasRelatedWork W2369852829 @default.
• W4379280904 hasRelatedWork W2372442000 @default.
• W4379280904 hasRelatedWork W2375265431 @default.
• W4379280904 hasRelatedWork W2377198612 @default.
• W4379280904 hasRelatedWork W2394317912 @default.
• W4379280904 hasRelatedWork W3003421087 @default.
• W4379280904 hasVolume "41" @default.
• W4379280904 isParatext "false" @default.
• W4379280904 isRetracted "false" @default.
• W4379280904 workType "article" @default.